EUROPEAN JOURNAL OF

PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

 ISSN (O) : 2394-3211

 ISSN (P) : 3051-2573

Impact Factor: 8.158

ICV - 79.57

Abstract

COMPARISON THE TREARMENT RESULTS OF TAMSULOSIN AND DOXAZOSIN IN THE MANAGEMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERTROPHY

Mounzer Alessa*, Hassan Naser and Isaac Mohanna

ABSTRACT

Background: The incidence of LUTS related to benign prostate hyperplasia (BPH) increases to 70% by the age of 80, which seriously affects the quality of life. Moreover these symptoms are associated with substantial personal and social problems. Although there are several options of drugs for treatment the LUTS related to BPH, a1-blockers are still the first-line drugs, and doxazosin and tamsulosin are the most popular ones worldwide. Objective: This study aims to evaluate the effectiveness and the safety of the tamsulosin and doxazosin in management of lower urinary tract symptoms associated with benign prostatic hypertrophy, and determine which one is more effective than the other. Methods and materials: Patients aged between 50-80 years and diagnosed with benign prostate hyperplasia (BPH) with International Prostatic Symptom Score (IPSS) total symptom score >8 were included. A total of 100 patients were randomized to treatment with 4mg of doxazosin daily (n = 50) or 0.4 mg of tamsulosin daily (n = 50) for 12 weeks. Efficacy was assessed at 0 weeks,6 weeks and 12 weeks of treatment ,using total IPSS, storage subscore and voiding subscore to determine changes in LUTS and urinary flow rates. Adverse events (AE) were recorded at each visit based on patient reports. QOL was assessed by the ‘quality of life due to urinary symptoms’ question from the IPSS questionnaire. Results: The total IPSS, voiding IPSS and storage IPSS each had decreased significantly after 12 weeks of treatment in the doxazosin group (P<0.05). However, only the T-IPSS had decreased significantly after 12 weeks of treatment in the tamsulosin group (P<0.05),while the decrease occurred in V-IPSS and S- IPSS in the tamsulosin group had no significance (P>0.05). However the improvement occurred in the QOL was significant in either the doxazosin and tamsulosin groups (P<0.05). Conclusion: Our results show superior efficacy of doxazosin over tamsulosin in terms of S-IPSSS and V- IPSS. Thus, doxazosin is superior to tamsulosin in the management of LUTS in patients with BPH.

Keywords: Doxazosin, Tamsulosin, BPH, IPSS.


[Full Text Article] [Download Certificate]

EJMPR Citation Report

  All Since 2021
 Citation  4339  2797
 h-index  23  20
 i10-index  109  52

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2026 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2026 issue has been successfully launched on 1 NOVEMBER 2026.

  • EJPMR: New Impact Factor 2026

    EJPMR Impact Factor has been Increased from 7.065 to 8.158, for Year 2026

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

BEST ARTICLE AWARDS

European Journal of Pharmaceutical and Medical Research is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Prof. Dr. Dhrubo Jyoti Sen
Download Article : Click Here

Google Scholar

Indian Science Publications

InfoBase Index (In Process)

SOCOLAR, China

Research Bible, Fuchu, Tokyo. JAPAN

International Society for Research activity (ISRA)

Scientific Indexing Services (SIS)

Polish Scholarly Bibliography

Global Impact Factor (GIF) (Under Process)

Universal Impact Factor

International Scientific Indexing (ISI), UAE

Index Copernicus

CAS (A Division of American Chemical Society) USA (Under Process)

Directory of Open Access Journal (DOAJ, Sweden, in process)

UDLedge Science Citation Index

CiteFactor

Directory Of Research Journal Indexing (DRJI)

Indian citation Index (ICI)

Journal Index (JI, Under Process)

Directory of abstract indexing for Journals (DAIJ)

Open Access Journals (Under Process)

Impact Factor Services For International Journals (IFSIJ)

Cosmos Impact Factor

Jour Informatics (Under Process)

Eurasian Scientific Journal Index (ESJI)

International Innovative Journal Impact Factor (IIJIF)

Science Library Index, Dubai, United Arab Emirates

Pubmed Database [NLM ID: 101669306] (Under Process)

IP Indexing (IP Value 2.40)

Web of Science Group (Under Process)

Directory of Research Journals Indexing

Scholar Article Journal Index (SAJI)

International Scientific Indexing ( ISI )

Scope Database

Academia

Doi-Digital Online Identifier

ISSN National Centre

Zenodo Indexing

International CODEN Service, USA